Review: Non-respiratory Indications for Psg in Children

1451 Polysomnography and Related Procedures in Children—Kotagal et al 1.0 INTRODUCTION In the last three decades, the knowledge and practice of pediatric sleep medicine has grown dramatically, as reflected in the exponential growth of peer reviewed publications regarding pediatric polysomnography (PSG). Comprehensive, attended, in-laboratory (level I) PSG is most often conducted to evaluate and/or monitor treatment of sleep-related breathing disorders (SRBD), including obstructive sleep apnea (OSA). Less commonly, PSG is performed to characterize the nature of recurring paroxysmal nocturnal events, sleep-related movements or behaviors, or hypersomnia. In 2007, the American Academy of Sleep Medicine (AASM) Standards of Practice Committee (SPC) and the Board of Directors empowered a task force to provide an evidence-based review of the indications for pediatric PSG. The task force was directed to analyze and summarize the evidence for respiratory and non-respiratory indications for PSG in infants, children and adolescents. The task force identified approximately 3,500 candidate papers in initial searches, most of which focused on respiratory indications for PSG. With approval of the AASM SPC and Board of Directors, the task force decided that the REVIEW: NON-RESPIRATORY INDICATIONS FOR PSG IN CHILDREN